Bafna Pharmaceuticals Limited
NSE: BAFNAPH | Information Technology
Market Fundamentals
Stock Intelligence & News
Bafna Pharmaceuticals Limited
BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →Bafna Pharmaceuticals Limited
BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited has informed the Exchange about retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 22, 2026 |SUBJECT: Retirement
Read Full Analysis →Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the Audited Financial Results of the Company for the Quarter & Year ended March 31, 2026 as published in "Financial Express" and "Makkal Kural" on May 31, 2026. |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Bafna Pharmaceuticals Limited
SRJR Lifesciences LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Barbell Strategy For Fixed Income: Here's What Debt Fund Managers Use To Navigate Yield Volatility — Explained
According to Basant Bafna of Mirae Asset Mutual Fund, the 'barbell' strategy broadly involves allocating money at both ends of the duration spectrum rather than concentrating investments in the middle.
Read Full Analysis →Bafna Pharmaceuticals Limited
Financial Results |Meeting Date: 29-May-2026
Read Full Analysis →Bafna Pharmaceuticals Limited
BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 . |SUBJECT: Board Meeting Intimation
Read Full Analysis →Bafna Pharmaceuticals Limited
Significant movement in price has been observed in Bafna Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Bafna Pharmaceuticals Limited has submitted their response. |SUBJECT: Price movement
Read Full Analysis →Get instant alerts when BAFNAPH breaks news
Join investors who track Bafna Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for BAFNAPH?
BAFNAPH is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Bafna Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding BAFNAPH to your custom watchlist.